Continuous-use and 21-day LNG/EE Produce Similar Results

Published Online: Saturday, July 1, 2006

A phase 3, randomized, open-label, multicenter study was conducted at 44 sites in Europe to evaluate 2 different doses of Wyeth's oral levonorgestrel (LNG) and ethinyl estradiol (EE) over 1 year: continuous daily, noncyclic LNG 90 μg/EE 20 μg and 21-day cyclic LNG 100 μg/EE 20 μg. The study involved ~641 women who took either version of the oral contraceptive in the form of 13 pill packs over the course of 12 months. The study authors noted that a majority of women taking the continuous daily LNG/EE combination reported amenorrhea: 27.1% at pill pack 3, 39.6% at pill pack 7, and 52.9% at pill pack 13. The researchers also noted an increase in the percentage of participants who experienced no bleeding with subsequent pill packs: 50%, 69%, and 79% at packs 3, 7, and 13, respectively. The researchers concluded that these results showed that the noncyclic regimen has a similar safety profile, compared with the established 21- day regimen. The study results were presented at the Annual Meeting of the American College of Obstetricians and Gynecologists on May 8, 2006.

Ms. Farley is a freelance medical writer based in Wakefield, RI.

Latest Articles
The FDA has approved Boehringer Ingelheim’s oral direct thrombin inhibitor dabigatran etexilate mesylate (Pradaxa) for the prophylaxis of deep vein thrombosis and pulmonary embolism in patients who have had hip replacement surgery.
As a result of implementation difficulties, the FDA announced that it will extend the pharmacy certification deadline for the clozapine risk evaluation and mitigation strategy program.
Pharmacies are rated as some of the best places to receive top-notch customer service in America.
Often caused by acid reflux, eosinophilic esophagitis is an emerging inflammatory disease that is generally unresponsive to proton pump inhibitor therapy.
Latest Issues